Preoperative carcinoembryonic antigen elevation in colorectal cancer

Hepato-Gastroenterology

Volumn 58, Issue 109, 2011, Pages 1171-1176

  Yeh, Chien Yuh ^a   Hsieh, Pao Shiu ^a   Chiang, Jy Ming ^a   Lai, Cheng Chou ^a   Chen, Jinn Shiun ^a   Wang, Jeng Yi ^a   Hung, Hsin Yuan ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

CEA; Colorectal adenocarcinoma

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANCER RISK; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

ADULT; AGED; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS;

EID: 83355170493     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge10564     Document Type: Article

References (21)

1. Wolmark N, Fisher B, Wieand HS, Henry RS, Lerner H, Legault S, Deckers PJ, Dimitrov N, Gordon PH, Jochimsen P: The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Results from NSABP clinical trials. Ann Surg 1984; 199:375-382. (Pubitemid 14139870)
2. Wang J Y, Lu CY, Chu KS, Ma CJ, Wu DC,Tsai HL, Yu FJ, Hsieh JS: Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer. European Surgical Research 2007; 39:245-250. (Pubitemid 47000372)
3. Herrera MA, Chu TM, Holyoke ED: Carcinoembryonic antigen(CEA) as a prognostic and monitoring test in clinically complete resection of colorectal carcinoma. Ann Surg 1976; 183:5-9.
4. Wanebo HJ, Rao B, Pinsky CM, Hoffman RG, Stearns M, Schwartz MK, Oettgen HF: Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med 1978; 299:448-451. (Pubitemid 9011330)
5. Steele G, Zamcheck N: The use of carcinoembrionic antigen in the clinical management of patients with colorectal cancer. Cancer Detect Prev 1985; 8:421-427.
6. Gold P, Freeman SO: Demonstration of tumor specific antigen in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965; 121:439-462.
7. Szymendera JJ, Nowacki MP, Szawlowski AW, Kamińska JA: Predictive value of plasma CEA levels: preoperative prognosis and postoperative monitoring of patients with colorectal carcinoma. Dis Colon Rectum 1982; 25:46-52. (Pubitemid 12164961)
8. Wiratkapun S, Kraemer M, Seow-Choen F, Ho YH, Eu KW: High preoperative serum carcinoembryonic antigen predict metastatic recurrence in potentially curative colonic cancer: results of a 5-year study. Dis Colon Rectum 2001; 44:231-235. (Pubitemid 32173772)
9. Marchena J, Acosta MA, Garcia-Anguiano F, Simpson H, Cruz F: Use of the preoperative levels of CEA in patients with colorectal cancer. Hepatogastroenterology 2003; 50:1017-1020. (Pubitemid 36723830)
10. Arnaud JP, Koehl C, Adloff M: Carcinoembryonal antigen (CEA) in diagnosis and prognosis of colorectal carcinoma. Dis Colon Rectum 1980; 23:141-144. (Pubitemid 10116217)
11. Schiemann U, Günther S, Gross M, Henke G, Müller-Koch Y, König A, Muders M, Folwaczny C, Mussack T, Holinski-Feder E: Preoperative serum levels of the carcinoembryonic antigen in hereditary non-polyposis colorectal cancer compared to levels in sporadic colorectal cancer. Cancer Detect Prev 2005; 29:356-360. (Pubitemid 41267294)
12. Uehara M, Manaka D, Baba S, Oji Y, Hirata K, Shimizu M, Noguchi M: Prognostic study of preoperative serum levels of CEA and CA 19-9 in colorectal cancer. Gan To Kagaku Ryoho. 2007; 34:1413-1417.
13. Reiter W, Stieber P, Reuter C, Nagel D, Lau-Werner U, Lamerz R: Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. Anticancer Research 2000; 20:5195-198. (Pubitemid 32319106)
14. Miki C, Inoue Y, Hiro J, Ojima E, Araki T, Uchida K, Kusunoki M: Combined measurement of hepatocyte growth factor and carcinoembryonic antigen as a prognostic marker for patients with dukes A and B colorectal cancer: results of a five-year study. Dis Colon Rectum 2006; 49:1710-1718. (Pubitemid 44800488)
15. Ma CJ, Hsieh JS, Wang WM, Su YC, Huang CJ, Huang TJ, Wang JY: Multivariate analysis of prognostic determinants for colorectal cancer patients with high preoperative serum CEA levels: prognostic value of post operative serum CEA levels. Kaohsiung Journal of Medical Sciences 2006; 22:604-609.
16. Seifert JK, Morris DL: Low preoperative serum carcinoembryonic antigen concentration is a marker of good prognosis in patients undergoing cryotherapy for low volume hepatic metastases from colorectal cancer. Int J Surg Investig 2000; 2:327-334.
17. Wang WS, Chen PM, Chiou TJ, Liu JH, Fan FS, Lin TC, Jiang JK, Yang SH, Yen CC, Wang HS, Lin JK: Factors predictive of survival in patients with node-positive colorectal cancer in Taiwan. Hepatogastroenterology 2000; 47:1590-1594.
18. Katoh H, Yamashita K, Kokuba Y, Satoh T, Ozawa H, Hatate K, Ihara A, Nakamura T, Onozato W, Watanabe M: Diminishing impact of preoperative carcinoembryonic antigen (CEA) in prognosis of Dukes' C colorectal cancer. Anticancer Research 2008; 28:1933-1941. (Pubitemid 351892909)
19. Wang WS, Lin JK, Lin TC, Chiou TJ, Liu JH, Yen CC, Chen WS, Jiang JK, Yang SH, Wang HS, Chen PM: EIA versus RIA in detecting carcinoembryonic antigen level of patients with metastatic colorectal cancer. Hepatogastroenterology 2004; 51:136-141.
20. Takagawa R, Fujii S, Ohta M, Nagano Y, Kunisaki C, Yamagishi S, Osada S, Ichikawa Y, Shimada H: Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer. Ann Surg Oncol 2008; 15:3433-3439.
21. Yoon-Ah P, Kang YL, Nam KK, Seung HB, Seung KS, Chang Whan C: Prognostic Effect of Perioperative Change of Serum Carcinoembryonic Antigen Level: A Useful Tool for Detection of Systemic Recurrence in Rectal Cancer. Annals of Surg Oncol 2006; 13:645-650.